Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GCAR1 in Alveolar Soft Part Sarcoma
NCT06827886Phase 1Completed
- Sponsor
- American Health Staffing Group
- Start
- Sep 2023
- Primary completion
- Sep 2024
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of GCAR1 in alveolar soft part sarcoma (ASPS), sponsored by American Health Staffing Group. Primary endpoints: Assess safety of GCAR1 at 1 year and Assess for anti-tumor activity at 1 year. Started Sep 2023; status: completed.
02
Drugs
GCAR1
03
Conditions
alveolar soft part sarcoma (ASPS)
Beyond the preview
Go deeper on NCT06827886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06827886.